表柔比星联合卡介苗膀胱灌注预防膀胱癌术后复发的疗效分析被引量：2

引文网络
相关文献

参考文献3

1Epirubicin : a review of its intravesical use in superficial bladder cancer. Drugs Aging, 1999,15:307 - 333. Onrust SV, Wiseman LR, Goa KL.
2邬喻,曾甫清,夏伟.表柔比星、卡介苗预防非肌层浸润性膀胱癌术后复发的荟萃分析[J].中国癌症杂志,2007,17(3):240-244. 被引量：4
3张向波,王志平,段建敏,王家吉,秦大山,岳中瑾,王一辰,刘国栋.表阿霉素加卡介苗膀胱灌注预防膀胱癌术后复发的疗效观察[J].中华泌尿外科杂志,2004,25(9):622-624. 被引量：12

二级参考文献17

1Soloway MS,Perito PE.Superficial bladder cancer:diagnosis,surveillance and treatment[J].J Cell Biochem Suppl,1992,16(I):120-127.
2Pavone-Macaluso M,Tripi M,Ingargiola GB,et al.Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer.The present role of epirubicin and doxorubicin[J].J Chemother,1993,5(3):207-211.
3Cheng CW,Chan SF,Chan LW,et al.Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer[J].Int J Urol,2005,12(5):449-455.
4Cheng CW,Chan SF,Chan LW,et al.15-year experience on intravesical therapy of T1G3 urinary bladder cancer:a conservative approach[J].Jpn J Clin Oncol,2004,34(4):202-205.
5Uekado Y,Hirano A,Shinka T,et al.The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guerin for prophylaxis of recurrence of superficial bladder cancer:a preliminary report[J].Cancer Chemother Pharmacol,1994,35(Suppl):S65-68.
6Ali-El-Dein B,Nabeeh A,Ismail EH,et al.Sequential bacillus Calmette-Guerin and epirubicin versus bacillus Calmette-Guerin alone for superficial bladder tumors:a randomized prospective study[J].J Urol,1999,162(2):339-342.
7Huncharek M,Kupelnick B.Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder:metaanalytic reevaluation[J].Am J Clin Oncol,2003,26(4):402-407.
8Sylvester RJ,van der Meijden AP,Witjes JA,et al.Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder:a meta-analysis of the published results of randomized clinical trials[J].J Urol,2005,174(1):86-91;discussion 91-92.
9Pawinski A,Sylvester R,Kurth KH,et al.A combined analysis of European Organization for Research and Treatment of Cancer,and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer.European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer[J].J Urol,1996,156(6):1934-1940,discussion 1940-1941.
10Bilen CY,Ozen H,Aki FT,et al.Clinical experience with BCG alone versus BCG plus epirubicin[J].Int J Urol,2000,7(6):206-209.